Chronic Pancreatitis Linked to Exocrine Insufficiency
A new study identifies high rates of pancreatic insufficiency in patients, highlighting smoking as a key risk factor.
Updated on Sept. 29, 2026 in Diabetes
Live Poll
Should doctors adopt standardized screening protocols based on new research findings for chronic conditions?
A systematic review and meta-analysis published in the Journal of Pancreatology found that 40 percent of patients with chronic pancreatitis develop exocrine pancreatic insufficiency (EPI). This widespread condition suggests a significant need for monitoring among those managing chronic pancreatic health.
Why it matters
Understanding the prevalence of EPI helps clinicians and patients better manage the long-term complications of chronic pancreatitis. Identifying modifiable risk factors like smoking provides a concrete path for patients to potentially mitigate disease progression.
This systematic review and meta-analysis of 14 studies covering 7,663 patients found a 40% prevalence of EPI, with smoking associated with 51% greater odds of the condition. Researchers used a random effects model to synthesize findings from studies conducted between 2004 and 2024.
The players
Journal of Pancreatology
A peer-reviewed medical publication focused on clinical and basic research related to pancreatic diseases.
The details
EPI occurs when the pancreas fails to produce enough enzymes to properly digest food, leading to nutrient malabsorption. The researchers found that diagnostic results varied by method: fecal elastase-1 testing indicated a 52.1% prevalence, the 13C-mixed triglyceride breath test showed 31.6%, and fecal fat testing showed 21.1%. Smoking may impair pancreatic function by inducing oxidative stress and damaging the delicate tissues responsible for enzyme secretion.
Timeline
Studies included in the review span from November 2004 to November 2024.
The meta-analysis was published on September 29, 2026.
Health Landscape
This study marks a significant update to the prevalence figures previously established in the Journal of Pancreatology research pipeline. It underscores a shift toward recognizing smoking as a critical, modifiable driver in the progression of pancreatic complications.
If you are managing chronic pancreatitis, you may want to discuss your risk of EPI and the necessity of enzyme screening with your physician. This study further reinforces that quitting smoking is a vital preventive step for maintaining better pancreatic and digestive function.
The takeaway
Chronic pancreatitis frequently results in exocrine pancreatic insufficiency, a condition where the body struggles to digest food properly. Patients should consult their care team about regular monitoring for nutrient malabsorption and the benefits of smoking cessation.
Further reading
For more on how chronic conditions impact metabolic health, see our latest research in Diabetes.
Live Poll
Should doctors adopt standardized screening protocols based on new research findings for chronic conditions?
